serine/threonine protein kinase) and cocaine-induced paranoia (4.86×10−8 in AAs and 0.0502 in EAs), and NCOR2 (nuclear receptor corepressor 2) and CD symptom count (p=1.19×10−9 in EAs). These Phase 1 (discovery sample) results, some reaching GWS, were not replicated. Although these may be false positive findings, which is more likely when the MAF is <5% (as for rs72840936 and NCOR1), our replication samples were smaller than the discovery sample, so that lack of replication in later study phases could reflect inadequate statistical power.
